On July 20, 2010
A Glass Half Full: Avandia Case Reveals Hole in FDA’s Conflict-of-Interest Rules
The news that one of the doctors on an FDA panel assessing whether GlaxoSmithKline (GSK)’s diabetes drug Avandia causes too many heart attacks failed to disclose he was a paid speaker for the company points out a giant hole in
…
0 Comments